University of Electronic Science and Technology of China
Chengdu, Sichuan, 611731, China
Location status: Recruiting
NCT Number: NCT07162584
The presnet study is to investigate the effect of intranasal oxytocin (24 IU) treatment on modulating how human responsd to threat in a dynamic situation.
Interested in participating?
Request Info18 year–35 year
All sexes
Interventional
Not applicable
Chengdu, Sichuan, 611731, China
Location status: Recruiting
Predator-prey interactions are inherently dynamic, requiring adaptive responses from prey to survive. Altough there is eviedence for oxytocin modulating anxiety and fear responses to threats, it remains unclear whether oxytocin (OT) would modulate how humans respond to threats along the predatory imminence continuum to facilitate escape during such interactions. Our study therefore focuses on this question by combining behavioralmeasures, skin conductance response, and fMRI in a dynamic predator-prey interaction paradigm. In this double-blind, between-subject, placebo-controlled study, participants are instructed to escape by evaluating the relative distance between themselves (i.e., the prey), the predator (slow, medium and high attacking speed) and the refuge. The MRI and Biopac electrophysiological acquisition systems are used in the study to collect subjects' brain activity and skin conductance response. Participants are also asked to rate their confidence and anxiety levels during performing the task. We will aslo examine the resulted patterns of flight initiation distance (FID) and distance to refuge (DTR) when the prey fled from different predators. Scores of questionnaires including Positive and Negative Affect Schedule, State-Trait Anxiety Inventory, Beck Depression Inventory-Ⅱ, Autism Spectrum Quotient, Sensitivity to Punishment and Sensitivity to Reward Questionnaire, General Risk Propensity Scale are also collected before the experiment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
intranasal administration of oxytocin (24 IU)
intranasal administration of placebo (24 IU)
Time frame: 1 hour
Escape sucess rates in successfully entering the refuge when confronting the fast, medium and slow predators.
Time frame: 1 hour
It is the prey-predator distance when a prey flees from a threat, a key index quantifying escape decisions.
Time frame: 1 hour
The distance to refuge when a prey flees from a threat.
Time frame: 1 hour
Brain activity patterns in response to different predators along the predatory imminence continuum. We will examine these brain response patterns via both the conventional univariate analysis and the machine learning-based multivariate pattern analysis (MVPA) approaches. Based on previous studies, the medium predator is a priori used as an anchor for fast and slow predators for a more sensitive measure of brain activity differences and contrasts with the medium predator would be reported in the suplemental files for completeness (if there were significant effects).
Time frame: 1 hour
Participants are asked to rate their confidence levels in successfully escaping from the predator before each block.
Time frame: 1 hour
Particioants are asked to rate how anxious they felt during the escape decision-making process.
Time frame: 1 hour
Skin Conductance Response (SCR) data are recorded in the task during scanning.
Contact information is provided by the study sponsor or research team.
University of Electronic Science and Technology of China
Other
The Modulatory Affect of Oxytocin on Human Defensive Responses During Dynamic Predator-prey Interactions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686393
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT07669077
Healthy
Salt Lake City, Utah, United States
View Trial DetailsNCT07169630
Alzheimer s Disease, Cognition Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT07739238
Healthy
Balıkesir, In the USA Or Canada, Please Select..., Turkey (Türkiye)
View Trial Details